SciRhom GmbH closes €63m Series A financing
German iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1362 entries already.
Entries by Thomas Gabrielczyk
Ligand Pharma to acquire Apeiron Biologics
/in News/by Thomas GabrielczykAustrian Apeiron Biologics goes to Ligand Pharmaceuticals for US$100m.
EMA-Gate: PharmaMar wins suit against EMA
/in News/by Thomas GabrielczykThe European Commission has fully upheld the complaint by PharmaMar SA due to conflicts of interest of leading EMA experts in the (non-)authorisation of Aplidin.
EuroscreenFast and GW Vitek announce distribution partnership in Korea
/in News/by Thomas GabrielczykBelgium-headquarted GCPR-screening specialist EuroscreenFast and Asian distributor GW Vitek have inked a strategic collaboration.
EMA-Gate: PharmaMar wins suit against EMA
/in News/by Thomas GabrielczykThe European Commission has fully upheld the complaint by PharmaMar SA due to conflicts of interest of leading EMA experts in the (non-)authorisation of Aplidin.
Novo Holdings and Abingworth co-lead £90m financing in Myricx Bio Ltd
/in News/by Thomas GabrielczykDanish Novo Holdings A/S and Abingworth co-led the largest European Series A financing round this year. Together with existing and new investors, they put £90m into cancer ADC specialist Myricx […]
Anacura aquires Ohmx.bio
/in News/by Thomas GabrielczykMerger within Ghent, Belgium: Anacura acquires OHMX.bio (both residing in neighborhood), adding multi-omics for drug discovery and diagnostics to its services.
Ten drug recommendations by EMA
/in News/by Thomas GabrielczykEMA’s human medicines committee (CHMP) recommended ten medicines for approval at its June 2024 meeting.
Semarion Ltd. wins Ignite SME award at SLAS Europe
/in News/by Thomas GabrielczykUK-based Semarion Ltd. was honoured as the most innovative company in the field of laboratory automation at SLAS Europe 2024 in Barcelona. <br /><br /><br />
MSD grabs Eyebiotech Ltd for US$1.3bn upfront
/in News/by Thomas GabrielczykUS pharma giant Merck Sharp & Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones. <div></div>